Shulgin described DOPR as a "heavy duty psychedelic", complete with alterations of the thought process and visual distortion. Very little data exists about the pharmacological properties, metabolism, and toxicity of DOPR.
Shulgin deemed DOPR a "strong psychedelic", featuring changes in thought patterns and visual experiences. Limited data exists on its pharmacological characteristics, metabolic processes, and potential hazards.